Delivery Order 75N91023D00005-75N91023F00001
Award Date
3/27/23
Potential Completion Date
3/26/24
Potential Value
$951K
Federal Agency
National Cancer Institute
Awardee
Regimed Medical
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
O'Fallon, MO 63376, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $780,240 delivery order contract to Regimed Medical of Frederick, Maryland. Under the terms of the contract, Regimed Medical will provide 112 blisters of 150mg Nilotinib capsules and 16 blisters of 200mg Nilotinib capsules in support of the DHHS, NIH, NCI, DCTD, CTEP. The fixed price contract runs from September 20, 2023 through September 19, 2024 and will be performed in Frederick,...
This is a delivery order awarded to Regimed Medical, a minority-owned small disadvantaged business located in O'Fallon, Missouri, under a $6.34 million Indefinite Delivery Contract (IDC) with the National Institutes of Health (NIH) National Cancer Institute. The delivery order, valued at $219,850.00, is for the procurement of 200 mg nilotinib tablets to support the NIH's Division of Cancer Treatment and Diagnosis and Cancer Therapy Evaluation Program. This requirement is not set-aside and is...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1.7 million delivery order contract to Regimed Medical to procure 240 blister packs of 150 mg nilotinib tablets and 40 blister packs of 200 mg nilotinib tablets in support of the Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program. The firm fixed price contract runs from November 17, 2023 through November 16, 2024 and will be performed in Frederick, Maryland.
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price purchase order contract to Regimed Medical, a minority-owned, self-certified small disadvantaged business, to provide pharmaceuticals and medical supplies for the VA's National CMOP (Consolidated Mail Outpatient Pharmacy) program. The $42,979.20 contract covers the delivery of various medications, including venlafaxine, nilotinib, and ferrous sulfate tablets, to VA medical centers and outpatient...
This is a firm fixed price delivery order awarded by the National Cancer Institute, part of the Department of Health and Human Services National Institutes of Health, to IIT Research Institute. The order is for preclinical efficacy evaluation of a lipid-based SMEDDS formulation of the drug compound DIM, BR-9001, as part of the NCI's Preclinical Prevent Cancer Program. The $970,988.47 contract has a completion date of February 7, 2022. IIT Research Institute is a non-profit research...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1.5 million delivery order contract to Leidos Biomedical Research Inc. to provide manufacturing of tumor-penetrating microparticles suitable for human use. The contract runs from September 15, 2023 through September 14, 2028 and utilizes a cost plus fixed fee pricing structure. Performance will take place in Fort Detrick, Maryland. No applicable subcontractors were identified.</p>
The National Cancer Institute (NCI) awarded a $73,009 cost-plus-fixed-fee delivery order to Societal CDMO San Diego, LLC, a self-certified small disadvantaged business doing business as Irisys Inc. The contract is for the production of 600 bottles of tetrahydrouridine powder, a compound used in cancer research. This order is part of Societal CDMO San Diego's multiple-award $45 million Drug Formulation and Manufacturing Contracts 2019 Indefinite Delivery Vehicle (IDV) with the National Institutes...
Novomedix LLC, a woman-owned small business, has been awarded a $355,000 firm fixed price contract from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to perform research and development on novel small molecules for the treatment of rhabdomyosarcoma, a rare cancer affecting muscle tissue. This is a Small Business Innovation Research (SBIR) concept award, which is a set-aside for small businesses. The contract has an ultimate completion date of June...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $2.4 million delivery order against the Toxicology of Drugs Developed for Cancer Patients master IDIQ contract to IIT Research Institute. Under this order, IIT Research Institute will provide toxicology services to support the preclinical development of EIF4A inhibitors rocaglamide and didesmethylrocaglamide from September 2020 through September 2023 in...
This firm-fixed-price delivery order was awarded to Societal CDMO San Diego, LLC (a division of Recro Pharma, Inc.) by the National Cancer Institute, part of the National Institutes of Health at the Department of Health and Human Services. The $546,667.00 contract is for the production of an engineering batch, current Good Manufacturing Practice (cGMP) batch, delivery, and shelf-life study of ammonium tetrathiomolybdate (ATTM) capsules to support a clinical trial for a potential cancer...